Actively Recruiting
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Led by Shengjing Hospital · Updated on 2026-03-11
300
Participants Needed
1
Research Sites
310 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.
CONDITIONS
Official Title
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of pulmonary embolism confirmed by CT pulmonary angiography
You will not qualify if you...
- Pregnancy
- Received reperfusion treatment before hospital admission
- Missing data on CT parameters, echocardiography, cardiac troponin I, or NT-pro BNP levels
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shenjing Hospital of CHINA MEDICAL UNIVERSITY
Shenyang, Liaoning, China
Actively Recruiting
Research Team
Y
YIZHUO GAO
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here